HEADER RECEPTOR 05-APR-11 2YFE TITLE LIGAND BINDING DOMAIN OF HUMAN PPAR GAMMA IN COMPLEX WITH AMORFRUTIN 1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: LIGAND BINDING DOMAIN, RESIDUES 195-477; COMPND 5 SYNONYM: PPAR-GAMMA, NUCLEAR RECEPTOR SUBFAMILY 1 GROUP C MEMBER 3; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET28A KEYWDS RECEPTOR, AGONIST, DIABETES, INSULIN RESISTANCE EXPDTA X-RAY DIFFRACTION AUTHOR J.C.DE GROOT,K.BUESSOW REVDAT 5 20-DEC-23 2YFE 1 REMARK REVDAT 4 23-MAY-12 2YFE 1 JRNL REVDAT 3 02-MAY-12 2YFE 1 JRNL REVDAT 2 25-APR-12 2YFE 1 JRNL REVDAT 1 11-APR-12 2YFE 0 JRNL AUTH C.WEIDNER,J.C.DE GROOT,A.PRASAD,A.FREIWALD,C.QUEDENAU, JRNL AUTH 2 M.KLIEM,A.WITZKE,V.KODELJA,C.-T.HAN,S.GIEGOLD,M.BAUMANN, JRNL AUTH 3 B.KLEBL,K.SIEMS,L.MUELLER-KUHRT,A.SCHUERMANN,R.SCHUELLER, JRNL AUTH 4 A.F.H.PFEIFFER,F.C.SCHROEDER,K.BUESSOW,S.SAUER JRNL TITL AMORFRUTINS ARE POTENT ANTIDIABETIC DIETARY NATURAL PRODUCTS JRNL REF PROC.NATL.ACAD.SCI.USA V. 109 7257 2012 JRNL REFN ISSN 0027-8424 JRNL PMID 22509006 JRNL DOI 10.1073/PNAS.1116971109 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0109 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 27.58 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 41449 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.207 REMARK 3 R VALUE (WORKING SET) : 0.204 REMARK 3 FREE R VALUE : 0.254 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2182 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.05 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3072 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 BIN R VALUE (WORKING SET) : 0.2800 REMARK 3 BIN FREE R VALUE SET COUNT : 162 REMARK 3 BIN FREE R VALUE : 0.3240 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4224 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 50 REMARK 3 SOLVENT ATOMS : 180 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 42.50 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 44.03 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.18000 REMARK 3 B22 (A**2) : 2.29000 REMARK 3 B33 (A**2) : -1.90000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.47000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.184 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.171 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.131 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 10.456 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.956 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.932 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4460 ; 0.011 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6024 ; 1.243 ; 2.007 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 549 ; 5.236 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 197 ;39.779 ;25.431 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 868 ;16.272 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 18 ;18.668 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 687 ; 0.084 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3276 ; 0.005 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2673 ; 0.679 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4345 ; 1.267 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1787 ; 1.918 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1666 ; 3.208 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 12 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 202 A 253 REMARK 3 ORIGIN FOR THE GROUP (A): 30.0397 8.1213 48.0970 REMARK 3 T TENSOR REMARK 3 T11: 0.1780 T22: 0.1826 REMARK 3 T33: 0.1897 T12: -0.0292 REMARK 3 T13: -0.0060 T23: 0.0010 REMARK 3 L TENSOR REMARK 3 L11: 1.5250 L22: 0.2534 REMARK 3 L33: 1.9563 L12: -0.5934 REMARK 3 L13: -0.5379 L23: 0.2685 REMARK 3 S TENSOR REMARK 3 S11: -0.1144 S12: -0.0868 S13: -0.0741 REMARK 3 S21: 0.0785 S22: 0.0838 S23: 0.0109 REMARK 3 S31: 0.0166 S32: 0.1258 S33: 0.0306 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 254 A 326 REMARK 3 ORIGIN FOR THE GROUP (A): 21.5331 19.4740 37.3516 REMARK 3 T TENSOR REMARK 3 T11: 0.2388 T22: 0.2217 REMARK 3 T33: 0.2276 T12: -0.0234 REMARK 3 T13: -0.0224 T23: 0.0205 REMARK 3 L TENSOR REMARK 3 L11: 1.3260 L22: 0.4266 REMARK 3 L33: 2.1870 L12: -0.6252 REMARK 3 L13: -1.0814 L23: 0.1131 REMARK 3 S TENSOR REMARK 3 S11: 0.0636 S12: 0.0796 S13: 0.1299 REMARK 3 S21: 0.0290 S22: 0.0506 S23: -0.0565 REMARK 3 S31: -0.3361 S32: -0.2008 S33: -0.1142 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 327 A 352 REMARK 3 ORIGIN FOR THE GROUP (A): 16.5713 14.5318 51.7419 REMARK 3 T TENSOR REMARK 3 T11: 0.2071 T22: 0.2392 REMARK 3 T33: 0.2107 T12: 0.0105 REMARK 3 T13: 0.0029 T23: 0.0177 REMARK 3 L TENSOR REMARK 3 L11: 0.6562 L22: 1.5568 REMARK 3 L33: 3.4778 L12: -0.7010 REMARK 3 L13: 0.0604 L23: 1.4699 REMARK 3 S TENSOR REMARK 3 S11: -0.1369 S12: -0.0203 S13: -0.0833 REMARK 3 S21: 0.0867 S22: 0.1531 S23: 0.0288 REMARK 3 S31: -0.1051 S32: -0.0732 S33: -0.0162 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 353 A 436 REMARK 3 ORIGIN FOR THE GROUP (A): 20.8981 3.3594 38.0339 REMARK 3 T TENSOR REMARK 3 T11: 0.1786 T22: 0.2046 REMARK 3 T33: 0.2368 T12: -0.0693 REMARK 3 T13: -0.0173 T23: -0.0163 REMARK 3 L TENSOR REMARK 3 L11: 0.6497 L22: 0.7506 REMARK 3 L33: 0.9957 L12: -0.3122 REMARK 3 L13: -0.1541 L23: 0.2512 REMARK 3 S TENSOR REMARK 3 S11: -0.0453 S12: 0.0784 S13: -0.0957 REMARK 3 S21: 0.0232 S22: 0.0202 S23: 0.1163 REMARK 3 S31: 0.0405 S32: -0.1195 S33: 0.0251 REMARK 3 REMARK 3 TLS GROUP : 5 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 437 A 461 REMARK 3 ORIGIN FOR THE GROUP (A): 7.8119 14.0980 35.5762 REMARK 3 T TENSOR REMARK 3 T11: 0.1532 T22: 0.3051 REMARK 3 T33: 0.2249 T12: -0.0885 REMARK 3 T13: -0.0746 T23: 0.0035 REMARK 3 L TENSOR REMARK 3 L11: 6.0782 L22: 21.7718 REMARK 3 L33: 0.5105 L12: -11.2497 REMARK 3 L13: 0.4126 L23: -1.4347 REMARK 3 S TENSOR REMARK 3 S11: 0.0304 S12: 0.2576 S13: -0.1113 REMARK 3 S21: -0.0591 S22: -0.0237 S23: 0.1648 REMARK 3 S31: -0.0010 S32: -0.2859 S33: -0.0067 REMARK 3 REMARK 3 TLS GROUP : 6 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 462 A 476 REMARK 3 ORIGIN FOR THE GROUP (A): 13.6774 24.3660 31.3541 REMARK 3 T TENSOR REMARK 3 T11: 0.5183 T22: 0.3447 REMARK 3 T33: 0.1505 T12: 0.2479 REMARK 3 T13: 0.0002 T23: 0.1594 REMARK 3 L TENSOR REMARK 3 L11: 8.0713 L22: 7.8884 REMARK 3 L33: 0.2795 L12: -7.9720 REMARK 3 L13: -1.4796 L23: 1.4556 REMARK 3 S TENSOR REMARK 3 S11: 0.7181 S12: 0.8840 S13: -0.0755 REMARK 3 S21: -0.6295 S22: -0.7708 S23: 0.1164 REMARK 3 S31: -0.1853 S32: -0.1881 S33: 0.0527 REMARK 3 REMARK 3 TLS GROUP : 7 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 206 B 239 REMARK 3 ORIGIN FOR THE GROUP (A): 10.9566 -22.3616 23.9428 REMARK 3 T TENSOR REMARK 3 T11: 0.2482 T22: 0.1664 REMARK 3 T33: 0.2563 T12: -0.0688 REMARK 3 T13: 0.0072 T23: -0.0765 REMARK 3 L TENSOR REMARK 3 L11: 1.5167 L22: 1.5950 REMARK 3 L33: 3.2633 L12: -0.7570 REMARK 3 L13: 0.2007 L23: -0.8111 REMARK 3 S TENSOR REMARK 3 S11: 0.0001 S12: 0.3276 S13: -0.2173 REMARK 3 S21: -0.0410 S22: 0.0352 S23: -0.1090 REMARK 3 S31: 0.2855 S32: 0.1471 S33: -0.0353 REMARK 3 REMARK 3 TLS GROUP : 8 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 240 B 277 REMARK 3 ORIGIN FOR THE GROUP (A): -8.3087 -10.6255 6.0915 REMARK 3 T TENSOR REMARK 3 T11: 0.2668 T22: 0.5017 REMARK 3 T33: 0.0670 T12: -0.0230 REMARK 3 T13: -0.0371 T23: -0.0684 REMARK 3 L TENSOR REMARK 3 L11: 1.9794 L22: 1.4079 REMARK 3 L33: 6.0729 L12: 0.7859 REMARK 3 L13: -1.2290 L23: 0.3349 REMARK 3 S TENSOR REMARK 3 S11: 0.2164 S12: 0.4626 S13: -0.2711 REMARK 3 S21: -0.0083 S22: -0.0852 S23: -0.0713 REMARK 3 S31: 0.3191 S32: -0.6734 S33: -0.1312 REMARK 3 REMARK 3 TLS GROUP : 9 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 278 B 334 REMARK 3 ORIGIN FOR THE GROUP (A): -1.6041 -12.2901 29.1646 REMARK 3 T TENSOR REMARK 3 T11: 0.1993 T22: 0.2110 REMARK 3 T33: 0.2249 T12: -0.0545 REMARK 3 T13: 0.0112 T23: -0.0001 REMARK 3 L TENSOR REMARK 3 L11: 1.0727 L22: 0.1764 REMARK 3 L33: 1.7378 L12: -0.0993 REMARK 3 L13: -0.0430 L23: 0.0857 REMARK 3 S TENSOR REMARK 3 S11: 0.0150 S12: 0.1318 S13: 0.0023 REMARK 3 S21: -0.0012 S22: 0.0034 S23: -0.0141 REMARK 3 S31: -0.0919 S32: -0.1962 S33: -0.0184 REMARK 3 REMARK 3 TLS GROUP : 10 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 335 B 371 REMARK 3 ORIGIN FOR THE GROUP (A): 0.3887 -2.1955 12.4207 REMARK 3 T TENSOR REMARK 3 T11: 0.3042 T22: 0.2899 REMARK 3 T33: 0.1253 T12: -0.0489 REMARK 3 T13: 0.0626 T23: 0.0401 REMARK 3 L TENSOR REMARK 3 L11: 2.9567 L22: 0.7074 REMARK 3 L33: 3.1382 L12: -1.3813 REMARK 3 L13: 1.3548 L23: -0.2595 REMARK 3 S TENSOR REMARK 3 S11: 0.0630 S12: 0.2010 S13: 0.1001 REMARK 3 S21: -0.0719 S22: -0.1404 S23: -0.0570 REMARK 3 S31: -0.4080 S32: -0.2363 S33: 0.0774 REMARK 3 REMARK 3 TLS GROUP : 11 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 372 B 437 REMARK 3 ORIGIN FOR THE GROUP (A): 15.0786 -12.5457 31.6989 REMARK 3 T TENSOR REMARK 3 T11: 0.1878 T22: 0.1903 REMARK 3 T33: 0.2434 T12: -0.0632 REMARK 3 T13: -0.0033 T23: -0.0339 REMARK 3 L TENSOR REMARK 3 L11: 1.5832 L22: 0.3892 REMARK 3 L33: 1.2063 L12: 0.1752 REMARK 3 L13: -0.5592 L23: -0.1971 REMARK 3 S TENSOR REMARK 3 S11: 0.0563 S12: 0.0152 S13: -0.0211 REMARK 3 S21: 0.0122 S22: 0.0281 S23: -0.1552 REMARK 3 S31: 0.0006 S32: 0.1144 S33: -0.0844 REMARK 3 REMARK 3 TLS GROUP : 12 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 438 B 474 REMARK 3 ORIGIN FOR THE GROUP (A): -7.3792 0.2448 26.4476 REMARK 3 T TENSOR REMARK 3 T11: 0.3100 T22: 0.2784 REMARK 3 T33: 0.5361 T12: -0.0446 REMARK 3 T13: 0.1527 T23: 0.0083 REMARK 3 L TENSOR REMARK 3 L11: 0.9672 L22: 2.7392 REMARK 3 L33: 1.7636 L12: -0.0278 REMARK 3 L13: -1.1233 L23: 0.8044 REMARK 3 S TENSOR REMARK 3 S11: 0.3106 S12: 0.1198 S13: 0.5199 REMARK 3 S21: -0.1454 S22: -0.0712 S23: 0.4923 REMARK 3 S31: -0.1732 S32: -0.2947 S33: -0.2394 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 2YFE COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 05-APR-11. REMARK 100 THE DEPOSITION ID IS D_1290047926. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-OCT-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 HF REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5419 REMARK 200 MONOCHROMATOR : RIGAKU VARIMAX REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU SATURN 944 PLUS REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 43633 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 27.500 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 3.100 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 6.700 REMARK 200 R MERGE (I) : 0.11000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 15.8200 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.15 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.8 REMARK 200 DATA REDUNDANCY IN SHELL : 6.00 REMARK 200 R MERGE FOR SHELL (I) : 0.64000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 1PRG REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.60 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.8M TRI-SODIUM CITRATE, 0.1M REMARK 280 IMIDAZOLE, PH 8.0 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 46.40500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 30.55000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 46.40500 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 30.55000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 191 REMARK 465 SER A 192 REMARK 465 HIS A 193 REMARK 465 MET A 194 REMARK 465 ALA A 195 REMARK 465 GLU A 196 REMARK 465 ILE A 197 REMARK 465 SER A 198 REMARK 465 SER A 199 REMARK 465 ASP A 200 REMARK 465 ILE A 201 REMARK 465 LYS A 263 REMARK 465 PHE A 264 REMARK 465 LYS A 265 REMARK 465 HIS A 266 REMARK 465 ILE A 267 REMARK 465 THR A 268 REMARK 465 PRO A 269 REMARK 465 LEU A 270 REMARK 465 GLN A 271 REMARK 465 GLU A 272 REMARK 465 GLN A 273 REMARK 465 TYR A 477 REMARK 465 GLY B 191 REMARK 465 SER B 192 REMARK 465 HIS B 193 REMARK 465 MET B 194 REMARK 465 ALA B 195 REMARK 465 GLU B 196 REMARK 465 ILE B 197 REMARK 465 SER B 198 REMARK 465 SER B 199 REMARK 465 ASP B 200 REMARK 465 ILE B 201 REMARK 465 ASP B 202 REMARK 465 GLN B 203 REMARK 465 LEU B 204 REMARK 465 ASN B 205 REMARK 465 LEU B 270 REMARK 465 GLN B 271 REMARK 465 GLU B 272 REMARK 465 GLN B 273 REMARK 465 SER B 464 REMARK 465 ASP B 475 REMARK 465 LEU B 476 REMARK 465 TYR B 477 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 393 54.78 -90.82 REMARK 500 GLU A 460 66.97 -110.55 REMARK 500 LYS B 244 83.29 51.26 REMARK 500 LEU B 393 49.26 -77.23 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 THR A 241 THR A 242 136.51 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH B2040 DISTANCE = 6.45 ANGSTROMS REMARK 650 REMARK 650 HELIX REMARK 650 DETERMINATION METHOD: AUTHOR PROVIDED. REMARK 700 REMARK 700 SHEET REMARK 700 DETERMINATION METHOD: AUTHOR PROVIDED. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE YFE A 999 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE YFE B 999 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2FVJ RELATED DB: PDB REMARK 900 A NOVEL ANTI-ADIPOGENIC PARTIAL AGONIST OF PEROXISOMEPROLIFERATOR- REMARK 900 ACTIVATED RECEPTOR-GAMMA (PPARG) RECRUITSPPARG-COACTIVATOR-1 ALPHA REMARK 900 (PGC1A) BUT POTENTIATES INSULINSIGNALING IN VITRO REMARK 900 RELATED ID: 2VV2 RELATED DB: PDB REMARK 900 HPPARGAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH 5-HEPA REMARK 900 RELATED ID: 1FM9 RELATED DB: PDB REMARK 900 THE 2.1 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THEHETERODIMER OF REMARK 900 THE HUMAN RXRALPHA AND PPARGAMMA LIGANDBINDING DOMAINS RESPECTIVELY REMARK 900 BOUND WITH 9-CIS RETINOIC ACIDAND GI262570 AND CO-ACTIVATOR REMARK 900 PEPTIDES. REMARK 900 RELATED ID: 2XKW RELATED DB: PDB REMARK 900 LIGAND BINDING DOMAIN OF HUMAN PPAR-GAMMA IN COMPLEX WITH THE REMARK 900 AGONIST PIOGLITAZONE REMARK 900 RELATED ID: 2VV0 RELATED DB: PDB REMARK 900 HPPARGAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH DHA REMARK 900 RELATED ID: 2VV1 RELATED DB: PDB REMARK 900 HPPARGAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH 4-HDHA REMARK 900 RELATED ID: 2PRG RELATED DB: PDB REMARK 900 LIGAND-BINDING DOMAIN OF THE HUMAN PEROXISOME PROLIFERATOR REMARK 900 ACTIVATED RECEPTOR GAMMA REMARK 900 RELATED ID: 1KNU RELATED DB: PDB REMARK 900 LIGAND BINDING DOMAIN OF THE HUMAN PEROXISOME PROLIFERATORACTIVATED REMARK 900 RECEPTOR GAMMA IN COMPLEX WITH A SYNTHETICAGONIST REMARK 900 RELATED ID: 1RDT RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A NEW REXINOID BOUND TO THE RXRALPHALIGAND REMARK 900 BINDING DOAMIN IN THE RXRALPHA/PPARGAMMA HETERODIMER REMARK 900 RELATED ID: 2VV4 RELATED DB: PDB REMARK 900 HPPARGAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH 6-OXOOTE REMARK 900 RELATED ID: 3PRG RELATED DB: PDB REMARK 900 LIGAND BINDING DOMAIN OF HUMAN PEROXISOME PROLIFERATOR ACTIVATED REMARK 900 RECEPTOR REMARK 900 RELATED ID: 1I7I RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE LIGAND BINDING DOMAIN OF HUMANPPAR-GAMMA REMARK 900 IN COMPLEX WITH THE AGONIST AZ 242 REMARK 900 RELATED ID: 1K74 RELATED DB: PDB REMARK 900 THE 2.3 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THEHETERODIMER OF REMARK 900 THE HUMAN PPARGAMMA AND RXRALPHA LIGANDBINDING DOMAINS RESPECTIVELY REMARK 900 BOUND WITH GW409544 AND 9-CISRETINOIC ACID AND CO-ACTIVATOR REMARK 900 PEPTIDES. REMARK 900 RELATED ID: 1FM6 RELATED DB: PDB REMARK 900 THE 2.1 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THEHETERODIMER OF REMARK 900 THE HUMAN RXRALPHA AND PPARGAMMA LIGANDBINDING DOMAINS RESPECTIVELY REMARK 900 BOUND WITH 9-CIS RETINOIC ACIDAND ROSIGLITAZONE AND CO-ACTIVATOR REMARK 900 PEPTIDES. REMARK 900 RELATED ID: 1ZGY RELATED DB: PDB REMARK 900 STRUCTURAL AND BIOCHEMICAL BASIS FOR SELECTIVE REPRESSIONOF THE REMARK 900 ORPHAN NUCLEAR RECEPTOR LRH-1 BY SHP REMARK 900 RELATED ID: 1PRG RELATED DB: PDB REMARK 900 LIGAND BINDING DOMAIN OF THE HUMAN PEROXISOME PROLIFERATOR REMARK 900 ACTIVATED RECEPTOR GAMMA REMARK 900 RELATED ID: 2F4B RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE LIGAND BINDING DOMAIN OF HUMANPPAR-GAMMA REMARK 900 IN COMPLEX WITH AN AGONIST REMARK 900 RELATED ID: 2VST RELATED DB: PDB REMARK 900 HPPARGAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH 13-(S) -HODE REMARK 900 RELATED ID: 2G0H RELATED DB: PDB REMARK 900 STRUCTURE-BASED DRUG DESIGN OF A NOVEL FAMILY OF PPARPARTIAL REMARK 900 AGONISTS: VIRTUAL SCREENING, X-RAY CRYSTALLOGRAPHYAND IN VITRO/IN REMARK 900 VIVO BIOLOGICAL ACTIVITIES REMARK 900 RELATED ID: 2VSR RELATED DB: PDB REMARK 900 HPPARGAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH 9-(S) -HODE REMARK 900 RELATED ID: 1WM0 RELATED DB: PDB REMARK 900 PPARGAMMA IN COMPLEX WITH A 2-BABA COMPOUND REMARK 900 RELATED ID: 4PRG RELATED DB: PDB REMARK 900 0072 PARTIAL AGONIST PPAR GAMMA COCRYSTAL REMARK 900 RELATED ID: 1NYX RELATED DB: PDB REMARK 900 LIGAND BINDING DOMAIN OF THE HUMAN PEROXISOME PROLIFERATORACTIVATED REMARK 900 RECEPTOR GAMMA IN COMPLEX WITH AN AGONIST REMARK 900 RELATED ID: 2VV3 RELATED DB: PDB REMARK 900 HPPARGAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH 4-OXODHA REMARK 900 RELATED ID: 2G0G RELATED DB: PDB REMARK 900 STRUCTURE-BASED DRUG DESIGN OF A NOVEL FAMILY OF PPARPARTIAL REMARK 900 AGONISTS: VIRTUAL SCREENING, X-RAY CRYSTALLOGRAPHY AND IN VITRO/IN REMARK 900 VIVO BIOLOGICAL ACTIVITIES DBREF 2YFE A 195 477 UNP P37231 PPARG_HUMAN 195 477 DBREF 2YFE B 195 477 UNP P37231 PPARG_HUMAN 195 477 SEQADV 2YFE GLY A 191 UNP P37231 EXPRESSION TAG SEQADV 2YFE SER A 192 UNP P37231 EXPRESSION TAG SEQADV 2YFE HIS A 193 UNP P37231 EXPRESSION TAG SEQADV 2YFE MET A 194 UNP P37231 EXPRESSION TAG SEQADV 2YFE GLY B 191 UNP P37231 EXPRESSION TAG SEQADV 2YFE SER B 192 UNP P37231 EXPRESSION TAG SEQADV 2YFE HIS B 193 UNP P37231 EXPRESSION TAG SEQADV 2YFE MET B 194 UNP P37231 EXPRESSION TAG SEQRES 1 A 287 GLY SER HIS MET ALA GLU ILE SER SER ASP ILE ASP GLN SEQRES 2 A 287 LEU ASN PRO GLU SER ALA ASP LEU ARG ALA LEU ALA LYS SEQRES 3 A 287 HIS LEU TYR ASP SER TYR ILE LYS SER PHE PRO LEU THR SEQRES 4 A 287 LYS ALA LYS ALA ARG ALA ILE LEU THR GLY LYS THR THR SEQRES 5 A 287 ASP LYS SER PRO PHE VAL ILE TYR ASP MET ASN SER LEU SEQRES 6 A 287 MET MET GLY GLU ASP LYS ILE LYS PHE LYS HIS ILE THR SEQRES 7 A 287 PRO LEU GLN GLU GLN SER LYS GLU VAL ALA ILE ARG ILE SEQRES 8 A 287 PHE GLN GLY CYS GLN PHE ARG SER VAL GLU ALA VAL GLN SEQRES 9 A 287 GLU ILE THR GLU TYR ALA LYS SER ILE PRO GLY PHE VAL SEQRES 10 A 287 ASN LEU ASP LEU ASN ASP GLN VAL THR LEU LEU LYS TYR SEQRES 11 A 287 GLY VAL HIS GLU ILE ILE TYR THR MET LEU ALA SER LEU SEQRES 12 A 287 MET ASN LYS ASP GLY VAL LEU ILE SER GLU GLY GLN GLY SEQRES 13 A 287 PHE MET THR ARG GLU PHE LEU LYS SER LEU ARG LYS PRO SEQRES 14 A 287 PHE GLY ASP PHE MET GLU PRO LYS PHE GLU PHE ALA VAL SEQRES 15 A 287 LYS PHE ASN ALA LEU GLU LEU ASP ASP SER ASP LEU ALA SEQRES 16 A 287 ILE PHE ILE ALA VAL ILE ILE LEU SER GLY ASP ARG PRO SEQRES 17 A 287 GLY LEU LEU ASN VAL LYS PRO ILE GLU ASP ILE GLN ASP SEQRES 18 A 287 ASN LEU LEU GLN ALA LEU GLU LEU GLN LEU LYS LEU ASN SEQRES 19 A 287 HIS PRO GLU SER SER GLN LEU PHE ALA LYS LEU LEU GLN SEQRES 20 A 287 LYS MET THR ASP LEU ARG GLN ILE VAL THR GLU HIS VAL SEQRES 21 A 287 GLN LEU LEU GLN VAL ILE LYS LYS THR GLU THR ASP MET SEQRES 22 A 287 SER LEU HIS PRO LEU LEU GLN GLU ILE TYR LYS ASP LEU SEQRES 23 A 287 TYR SEQRES 1 B 287 GLY SER HIS MET ALA GLU ILE SER SER ASP ILE ASP GLN SEQRES 2 B 287 LEU ASN PRO GLU SER ALA ASP LEU ARG ALA LEU ALA LYS SEQRES 3 B 287 HIS LEU TYR ASP SER TYR ILE LYS SER PHE PRO LEU THR SEQRES 4 B 287 LYS ALA LYS ALA ARG ALA ILE LEU THR GLY LYS THR THR SEQRES 5 B 287 ASP LYS SER PRO PHE VAL ILE TYR ASP MET ASN SER LEU SEQRES 6 B 287 MET MET GLY GLU ASP LYS ILE LYS PHE LYS HIS ILE THR SEQRES 7 B 287 PRO LEU GLN GLU GLN SER LYS GLU VAL ALA ILE ARG ILE SEQRES 8 B 287 PHE GLN GLY CYS GLN PHE ARG SER VAL GLU ALA VAL GLN SEQRES 9 B 287 GLU ILE THR GLU TYR ALA LYS SER ILE PRO GLY PHE VAL SEQRES 10 B 287 ASN LEU ASP LEU ASN ASP GLN VAL THR LEU LEU LYS TYR SEQRES 11 B 287 GLY VAL HIS GLU ILE ILE TYR THR MET LEU ALA SER LEU SEQRES 12 B 287 MET ASN LYS ASP GLY VAL LEU ILE SER GLU GLY GLN GLY SEQRES 13 B 287 PHE MET THR ARG GLU PHE LEU LYS SER LEU ARG LYS PRO SEQRES 14 B 287 PHE GLY ASP PHE MET GLU PRO LYS PHE GLU PHE ALA VAL SEQRES 15 B 287 LYS PHE ASN ALA LEU GLU LEU ASP ASP SER ASP LEU ALA SEQRES 16 B 287 ILE PHE ILE ALA VAL ILE ILE LEU SER GLY ASP ARG PRO SEQRES 17 B 287 GLY LEU LEU ASN VAL LYS PRO ILE GLU ASP ILE GLN ASP SEQRES 18 B 287 ASN LEU LEU GLN ALA LEU GLU LEU GLN LEU LYS LEU ASN SEQRES 19 B 287 HIS PRO GLU SER SER GLN LEU PHE ALA LYS LEU LEU GLN SEQRES 20 B 287 LYS MET THR ASP LEU ARG GLN ILE VAL THR GLU HIS VAL SEQRES 21 B 287 GLN LEU LEU GLN VAL ILE LYS LYS THR GLU THR ASP MET SEQRES 22 B 287 SER LEU HIS PRO LEU LEU GLN GLU ILE TYR LYS ASP LEU SEQRES 23 B 287 TYR HET YFE A 999 25 HET YFE B 999 50 HETNAM YFE AMORFRUTIN 1 FORMUL 3 YFE 2(C21 H24 O4) FORMUL 5 HOH *180(H2 O) HELIX 1 1 PRO A 206 SER A 225 1 20 HELIX 2 2 LYS A 230 THR A 238 1 9 HELIX 3 3 MET A 252 LYS A 261 1 10 HELIX 4 4 VAL A 277 LYS A 301 1 25 HELIX 5 5 LEU A 311 SER A 332 1 22 HELIX 6 6 ARG A 350 LYS A 354 1 5 HELIX 7 7 GLU A 365 ASN A 375 1 11 HELIX 8 8 ASP A 381 ILE A 392 1 12 HELIX 9 9 VAL A 403 ASN A 424 1 22 HELIX 10 10 LEU A 431 THR A 459 1 29 HELIX 11 11 PRO A 467 TYR A 473 1 7 HELIX 12 12 ALA B 209 SER B 225 1 17 HELIX 13 13 LYS B 230 LEU B 237 1 8 HELIX 14 14 MET B 252 LYS B 261 1 10 HELIX 15 15 VAL B 277 LYS B 301 1 25 HELIX 16 16 LEU B 311 SER B 332 1 22 HELIX 17 17 ARG B 350 LYS B 354 1 5 HELIX 18 18 GLU B 365 ASN B 375 1 11 HELIX 19 19 ASP B 381 ILE B 392 1 12 HELIX 20 20 VAL B 403 ASN B 424 1 22 HELIX 21 21 LEU B 431 THR B 459 1 29 HELIX 22 22 PRO B 467 ILE B 472 1 6 SHEET 1 1 1 PHE A 247 ILE A 249 0 SHEET 1 2 1 MET A 334 ASN A 335 0 SHEET 1 3 1 GLY A 338 ILE A 341 0 SHEET 1 4 1 GLY A 346 THR A 349 0 SHEET 1 5 1 PHE B 247 ILE B 249 0 SHEET 1 6 1 GLY B 338 ILE B 341 0 SHEET 1 7 1 GLY B 346 THR B 349 0 CISPEP 1 LYS A 358 PRO A 359 0 -1.13 CISPEP 2 LYS B 358 PRO B 359 0 -3.94 SITE 1 AC1 8 ARG A 280 ILE A 281 CYS A 285 ARG A 288 SITE 2 AC1 8 LEU A 330 ILE A 341 SER A 342 MET A 348 SITE 1 AC2 20 PHE B 226 LEU B 255 GLU B 259 PHE B 264 SITE 2 AC2 20 HIS B 266 ARG B 280 ILE B 281 CYS B 285 SITE 3 AC2 20 ARG B 288 SER B 289 ALA B 292 MET B 329 SITE 4 AC2 20 LEU B 330 LEU B 333 LEU B 340 ILE B 341 SITE 5 AC2 20 SER B 342 MET B 348 PHE B 363 MET B 364 CRYST1 92.810 61.100 118.220 90.00 102.78 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010775 0.000000 0.002444 0.00000 SCALE2 0.000000 0.016367 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008674 0.00000 MTRIX1 1 0.104510 -0.976930 0.186250 4.99266 1 MTRIX2 1 -0.984580 -0.128060 -0.119190 16.39462 1 MTRIX3 1 0.140290 -0.170920 -0.975250 62.70806 1